Blopress and Sepsis - a phase IV clinical study of FDA data

Summary:

Sepsis is reported as a side effect among people who take Blopress (candesartan cilexetil), especially for people who are female, 60+ old, have been taking the drug for < 1 month also take Lasix, and have Rheumatoid arthritis.

The phase IV clinical study analyzes which people have Sepsis when taking Blopress. It is created by eHealthMe based on reports of 7,451 people who have side effects when taking Blopress from the FDA, and is updated regularly.

What is Blopress?

Blopress has active ingredients of candesartan cilexetil. It is often used in high blood pressure. eHealthMe is studying from 7,479 Blopress users. Check the latest studies of Blopress.

What is Sepsis?

Sepsis (a severe blood infection that can lead to organ failure and death) is found to be associated with 2,522 drugs and 3,259 conditions by eHealthMe. Check the latest studies of Sepsis.

On Jul, 20, 2026

7,451 people reported to have side effects when taking Blopress.
Among them, 91 people (1.22%) have Sepsis.

Among these 91 people:

How long have people been on Blopress when they have Sepsis? *

What is the gender of people who have Sepsis when taking Blopress? *

female: 50.57 %
male: 49.43 %

What is the age of people who have Sepsis when taking Blopress? *

What are other drugs people take besides Blopress? *

What are other side effects people have besides Sepsis? *

Fever: 15 people, 16.48%
Neutrophil Count Decreased (less than normal number of neutrophil a type of blood cell): 14 people, 15.38%
Thrombocytopenia (decrease of platelets in blood): 13 people, 14.29%
Diarrhea: 12 people, 13.19%
Anaemia (lack of blood): 11 people, 12.09%
Pneumonia: 11 people, 12.09%
Acute Kidney Failure: 9 people, 9.89%
Disseminated Intravascular Coagulation (systemic activation of blood coagulation): 9 people, 9.89%
Constipation: 8 people, 8.79%
Renal Impairment (severely reduced kidney function): 7 people, 7.69%

What are the existing conditions these people have? *

Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 16 people, 17.58%
Myelodysplastic Syndrome (a group of conditions that occur when the blood-forming cells in the bone marrow are damaged): 12 people, 13.19%
Diabetes: 9 people, 9.89%
Osteoporosis (bones weak and more likely to break): 9 people, 9.89%
Colon Cancer: 6 people, 6.59%
Insomnia (sleeplessness): 5 people, 5.49%
Back Pain: 5 people, 5.49%
Type 2 Diabetes: 5 people, 5.49%
Constipation: 4 people, 4.40%
Renal Cell Carcinoma Stage Iv (stage iv renal cell cancer have cancer that has spread to other organs, such as the lungs, liver, bones, or brain, and may have spread to lymph nodes): 4 people, 4.40%

* Approximation only. Some reports may have incomplete information.

Do you take Blopress and have Sepsis?

- Check whether Sepsis is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Blopress:

Blopress (7,479 reports)

Sepsis treatments and more:

Sepsis (140,102 reports)

Browse all side effects of Blopress:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Sepsis:

Sepsis (2,522 drugs)

Browse all the conditions that are associated with Sepsis:

Sepsis (3,259 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on candesartan cilexetil (the active ingredients of Blopress) and Blopress (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.